Across TCGA pan-cancer cohorts, MIR548I4 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR548I4 data layer compared with 1 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR548I4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548I4 expression acts as an unfavorable survival marker.
KIRC, BRCA, and OV are the cancer types where MIR548I4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.